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ABSTRACT
Objectives: To study the inhibition of prostaglandin endoperoxide H synthase-2 (PHSH-2) for arylacetic acid derivatives.
Methods: This study was performed to evaluate the anti-inflammatory activity of the synthesized arylacetic acid derivatives through molecular 
docking via Discovery Studio 4.0 and Schrodinger Software. ADMET study was conducted to find the assessment on genotoxicology.
Results: The synthesized arylacetic acid derivatives were confirmed by nuclear magnetic resonance, liquid chromatography-mass spectrometry, and 
purity by high-performance liquid chromatography. The synthetic pathway is economical, industrial scalability and is achieved with high yield and 
purity. The in silico studies identified the active pocket and compared with the standard drug.
Conclusion: Results from this work conclude that the arylacetic acid derivatives have very good inhibition and very low binding energy toward the 
active pocket, hence can be considered as good inhibitors of PHSH-2 on comparison with iodosuprofen. The compounds qualified Lipinski rule of five 
and the ADMET results were non-mutagenic and non-carcinogenic.
Keywords: Arylacetic acid, 1 phenyl glycidyl ether protein, ADMET, In silico docking, Anti-inflammatory.
INTRODUCTION
Prostaglandins are lipids, present in human and animals which act as 
potential mediators in acute pain, inflammation, and hyperpyrexia. 
These lipids are synthesized not on a specific site but throughout 
the body. The remedial action of nonsteroidal anti-inflammatory 
drugs (NSAIDs) is exercised through the inhibition of prostaglandin 
G/H synthase (PGHS), which is expressed as two isoenzymes, termed 
PGHS-1 and PGHS-2 [1]. Most of the NSAIDs are non-selective to the 
target and causes side effects such as gastric irritation and ulceration. 
Finding a potential inhibitor for the inflammation is more challenging 
and promising in the field of drug discovery. Small molecular inhibitors 
with computational etiquette have been flourishing in diagnosing 
disease and curative intervention in earlier research [2-5]. With this 
inspiration, in silico docking studies have been deployed for recognition 
of PGHS-2 inhibitors. The small molecular drugs were synthesized 
and virtually screened for biological activities [6]. Some of the drugs 
which were used effectively in inhibiting the enzymes responsible for 
inflammation are represented in Fig. 1. On intense study of these drugs, 
we tried to synthesize analogous functional moiety of library molecules 
so that they may be useful in prediction of activity.
The main objective of this study is to provide a best industrial route in 
an economical method with high pure and high yield. These molecules 
are virtually screened for biological activity. In order to synthesize the 
library molecules containing acetic acid groups, various methods have 
been tried and implemented. To add to its credential, these compounds 
can be used in synthesis of many chiral drugs as resolving agent and 
chiral auxillary. To date, synthesized arylacetic acid derivatives were 
not screened for ADMET prediction, hence, we attempt to predict the 
biological activity and toxicology via docking method.
METHODS
Proton (1H- nuclear magnetic resonance [NMR]) and carbon-13 
(13C-NMR) magnetic resonance spectra were recorded at 300 MHz 
and 75 MHz, respectively, in acetone-d 6 at 25°C. Chemical shift values 
are reported in ppm with tetramethylsilane as an internal reference. 
J values are given in Hz. The mass spectra were done using GC-MS 
(SHIMADZU GC-MS QP 2010 -CI mode) or liquid chromatography-mass 
spectrometry (LC-MS) 6010 (electrospray ionization [ESI] mode). The 
starting materials were purchased from Sigma-Aldrich.
Synthesis of arylacetic acid derivatives
In a multi-neck flask, under nitrogen atmosphere, sodium hydroxide 
(~1.6-1.8 mol eq) was dissolved in dimethylformamide (DMF) and 
stirred for 10 minutes at 10-20°C. The appropriate aryl cyanide 
(0.75-0.85 mol eq) was slowly added to the flask for about 30 minutes 
and stirred at 20°C for 2-3 hrs. Alkyl bromide such as EtBr, iPrBr, and 
N BuBr (~0.95-1.2 mol eq) was dissolved in 100 ml DMF solvent and 
added slowly to the reaction mixture for 30 minutes by maintaining the 
temperature at below 15°C for 5-8 hrs. After completion of reaction, the 
mixture was quenched in water (100 ml) and tBME (200 ml), the layers 
were separated and the solvent was removed using vacuum distillation. 
The concentrated alkyl substituted aryl cyanide was used to next step 
without further purification.
The concentrated alkyl substituted aryl cyanide (0.5-0.6 mol eq) was 
dissolved in propylene glycol (100 ml) and added potassium hydroxide 
flakes in lot quantities (exothermic reaction) for 1 hr at below 10°C. 
The reaction mixture was heated to 130-140°C and maintained at the 
same temperature for 7-10 hrs. The reaction mixture was quenched in 
water-tBME, the layers were separated and subjected to pH adjustment 
using conc. HCl (pH=1.0-2.0). Then, purified using dichloromethane 
and concentrated under vacuum. The purity of the product was done 
using high-performance liquid chromatography (HPLC), and the yield 
of the obtained arylacetic acid was 80-85% with purity 99% as solid.
Compound 5: Following the general method described above, isopropyl 
bromide and benzyl cyanide reacted to give the product as colorless 
solid with HPLC purity 99.0% and yield: 75 g; 1 proton (H-NMR) (CDCl3) 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i4.15287
Research Article
69
Asian J Pharm Clin Res, Vol 10, Issue 4, 2017, 68-72
 Kandhaswamy et al. 
Chromatographic conditions
Instrument: Shimadzu 2010A with UV detector or equivalent.
Column: Zorbax SB C18, 150 mm × 4.6 mm, 3.5 µ or equivalent.
Flow rate: 1.0 ml/minute.
Detection: UV at 300 nm.
Column temperature: 25°C.
Sample compartment temperature: 25°C.
Injection volume: 10 µl.
Runtime: 10 minutes.
RESULTS
The general method for preparing arylacetic acids is outlined in 
scheme 1.
While comparing the previous research [7] on the synthesis of arylacetic 
acid derivatives involve lengthy route with low pure compounds, 
whereas the route of synthesis suggested in this study can be utilized 
in industrial scale with economic pathway and achieved with high pure 
and high yields. The synthesized arylacetic acid derivatives can be 
resolved further to give chiral arylacetic acids which have extraordinary 
use in the field of pharmaceutical chemistry and in drug synthesis.
Molecular docking studies
The three dimensional structure of the protein was retrieved from the 
RCSB with protein data bank (PDB) Id-1 phenyl glycidyl ether (PGE) 
with X-ray diffraction resolution of 3.5 Å5 [5,6]. The preparation of 
retrieved protein was executed using the prepare protein wizard of 
Fig. 1: Functional group similarity of prostaglandin G/H 
synthase-2
Table 1: Experimental data of synthesized compounds
Compound No Compound name Structure Time Yield* (%) ESI: m/z
1 2-phenylbutanoic acid 9 hrs 75 163.2
2 (4-fluorophenyl)butanoic acid 8 hrs 78 195.9
3 2-phenylpentanoic acid 8 hrs 69 177.0
4 4-fluorophenyl-3-methylbutanoic acid 10 hrs 72 195.7
5 3-methyl-2-phenylbutanoic acid 7 hrs 75 177.2
6 2-(4-fluorophenyl)-3-methyl-butanoic acid 8 hrs 86 195.1
7 2-phenylhexanoic acid 9 hrs 80 191.5
8 2-(-4-fluorophenyl)-hexanoic acid 7 hrs 74 209.1
*Batch size: 100 g scale, ESI: Electrospray ionization
δH 0.70 (d, 3H), 1.08 (d, 3H), 2.33 (m, 1H), 3.14 (m, 1H), 7.29 (m, 5H), 
10.99 (bs, 1H); 13C NMR (CDCl3) δC 20.10, 21.46, 31.55, 60.09, 127.46, 
129.54, 128.59, 137.72, and 180.59; GC-MS (CI; MeOH): M/z 133(100), 
[M+H] at m/z 179(2), M+ At m/z 193 (4); LC-MS (ESI): M/z 196.
All other compounds were analyzed by HPLC and the characterization 
using LC-MS in ESI mode were tabulated in Table 1.
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accelrys Discovery Studio 4.0 by applying CHARMm force field. Initially, 
all the internal ligands, water molecules, ions and metal elements were 
removed and inserted the missing atoms before minimization of target 
protein. Glide parameters were defined in a similar way as that of 
accelrys.
In this study, the inhibitory activity of compounds 1-8 was investigated 
using molecular docking studies which were performed in two different 
commercial software like Discovery Studio and Schrodinger. The 
protein PDB structure of 1PGE is in complex with the 8 ligands through 
hydrogen bonding and hydrophobic interactions.
DISCUSSION
To determine the molecular binding interaction of the 8 ligands, 
they were docked into the active binding site of PGE protein and the 
docking results are listed in Table 2. The PDB sum active site analysis 
discloses the hydrogen bonding of ligand with His388A, His386A, 
Arg120, Ser516A, His90A, Tyr355A, Ser530A, Glu520A and Tyr385A 
of the receptors having the bond distance~2.8 A. The best results 
were analyzed based on the docking score, non-bonded interactions 
and Glide energy. The binding energy, i.e., glide energy was calculated 
based on optimized potential for liquid simulations-all atom force 
field. On comparing, these synthesized ligands with that of cocrystal 
(iodosuprofen) in the 1PGE, the hydrogen bonding was similar and 
their binding energies were tabulated in Table 2. The interacting amino 
acids of 1PGE with iodosuprofen were Tyr 355, Arg120, Ser 530 and are 
shown in Fig. 2.
Significance of Arg120 residue
The molecular docking of the proposed active site of PGHS shows 
the −COOH group of compounds 5 and 2 located in a favorable position 
for interacting with the guanidinium group of Arg120 (Fig. 3). These 
data provide biochemical evidence of the importance of the Arg120 
residue [8] in PGHS-1 for interaction with arachidonic acid and NSAIDs 
containing a free carboxylic acid moiety [9-12].
Based on the results obtained from docking and ADMET studies, the 
best compounds determined are compounds 7, 3, and 8 (Fig. 4) and 
almost all compounds have been predicted to have good inhibition 
(Fig. 5).
The results indicated that the synthesized arylacetic acid derivatives 
have a predicted inhibiting activity almost similar to standard drug 
(Table 2). Hence, they may have anti-inflammatory activity.
ADMET study
The pharmacokinetic study [14] of the compounds 1-8 were predicted 
by Discovery Studio 4.0. ADMET 2D-graph was plotted against AlogP98 
Scheme 1: Preparation of arylacetic acid derivatives
Table 2: Docking result for synthesized compounds and comparison with 1PGE cocrystal
Compound Discovery studio Schrodinger
Rigid Flexible
Lib dock score Docking score Glide energy Docking score Glide energy
1PGE-cocrystal −5.30 −34.88
Compound 1 90.13 −9.17 −27.47 −6.34 −27.09
Compound 2 87.37 −7.23 −23.53 −5.39 −25.42
Compound 3 93.43 −9.37 −28.06 −5.05 −30.77
Compound 4 93.21 −7.28 −28.83 −4.97 −27.65
Compound 5 86.71 −7.42 −27.57 −8.32 −31.73
Compound 6 86.23 −7.46 −29.71 −5.66 −29.51
Compound 7 95.03 −8.04 −26.84 −4.22 −32.95
Compound 8 88.36 −7.28 −28.83 −5.39 −25.42
PGE: Phenyl glycidyl ether
Fig. 2: Prostaglandin H2 synthase-1 complexed with co-crystal P 
(2’-iodo-5’-thenoyl)-hydrotropic acid (iodosuprofen)
Fig. 3: Arg120 interaction with compounds 2 and 5
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Fig. 4: Overall interactions of 1 phenyl glycidyl ether with 
compound 8-2D-diagram
Fig. 5: Hydrogen bonding interaction between receptor and 
compound 8
Fig. 6: ADMET 2D-graph of compounds 1-8: AlogP98 versus polar 
surface area
versus polar surface area (Fig. 6). The absorption model corresponding 
to blood-brain barrier and human intestinal absorption is indicated 
with 95% and 98% confidence limit ellipses. The compounds found 
to have good absorption level and they are well within the limit. The 
ADMET aqueous solubility predicted at 25°C found to have good and 
optimal levels (Table 3). The hepatotoxic level for all the compounds 
was predicted to be 0 based on ADMET. The mutagenicity and 
carcinogenicity prediction found to be 0.
CONCLUSION
Eight derivatives of arylacetic acids were synthesized in very reasonable 
yields. ADMET results showed that the synthesized compounds were 
non-mutagenic and non-carcinogenic and they meet the criteria of 
Lipinski rule of five [13]. Based on molecular docking studies, very 
low binding energy and very good inhibition toward the active pocket, 
hence they can be considered as good inhibitors of prostaglandin 
endoperoxide H synthase-2 on comparison with the standard drug 
iodosuprofen. Hence, the synthesized compounds may have anti-
inflammatory activity.
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